These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 11784153

  • 1. 4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonists.
    Fletcher SR, Burkamp F, Blurton P, Cheng SK, Clarkson R, O'Connor D, Spinks D, Tudge M, van Niel MB, Patel S, Chapman K, Marwood R, Shepheard S, Bentley G, Cook GP, Bristow LJ, Castro JL, Hutson PH, MacLeod AM.
    J Med Chem; 2002 Jan 17; 45(2):492-503. PubMed ID: 11784153
    [Abstract] [Full Text] [Related]

  • 2. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.
    Rowley M, Hallett DJ, Goodacre S, Moyes C, Crawforth J, Sparey TJ, Patel S, Marwood R, Patel S, Thomas S, Hitzel L, O'Connor D, Szeto N, Castro JL, Hutson PH, MacLeod AM.
    J Med Chem; 2001 May 10; 44(10):1603-14. PubMed ID: 11334570
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs.
    Kongsamut S, Kang J, Chen XL, Roehr J, Rampe D.
    Eur J Pharmacol; 2002 Aug 16; 450(1):37-41. PubMed ID: 12176106
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, and pharmacological evaluation of piperidin-4-yl amino aryl sulfonamides: novel, potent, selective, orally active, and brain penetrant 5-HT₆ receptor antagonists.
    Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P.
    J Med Chem; 2012 Nov 08; 55(21):9255-69. PubMed ID: 23006002
    [Abstract] [Full Text] [Related]

  • 5. Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols.
    Peglion JL, Goument B, Despaux N, Charlot V, Giraud H, Nisole C, Newman-Tancredi A, Dekeyne A, Bertrand M, Genissel P, Millan MJ.
    J Med Chem; 2002 Jan 03; 45(1):165-76. PubMed ID: 11754589
    [Abstract] [Full Text] [Related]

  • 6. (3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: potent and selective antagonists of the serotonin 5-HT6 receptor.
    Ivachtchenko AV, Dmitriev DE, Golovina ES, Kadieva MG, Koryakova AG, Kysil VM, Mitkin OD, Okun IM, Tkachenko SE, Vorobiev AA.
    J Med Chem; 2010 Jul 22; 53(14):5186-96. PubMed ID: 20560595
    [Abstract] [Full Text] [Related]

  • 7. Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies.
    Campiani G, Morelli E, Gemma S, Nacci V, Butini S, Hamon M, Novellino E, Greco G, Cagnotto A, Goegan M, Cervo L, Dalla Valle F, Fracasso C, Caccia S, Mennini T.
    J Med Chem; 1999 Oct 21; 42(21):4362-79. PubMed ID: 10543880
    [Abstract] [Full Text] [Related]

  • 8. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels.
    Kuryshev YA, Brown AM, Wang L, Benedict CR, Rampe D.
    J Pharmacol Exp Ther; 2000 Nov 21; 295(2):614-20. PubMed ID: 11046096
    [Abstract] [Full Text] [Related]

  • 9. Novel brain penetrant benzofuropiperidine 5-HT₆ receptor antagonists.
    Sundar BG, Bailey TR, Dunn DD, Bacon ER, Salvino JM, Morton GC, Aimone LD, Zeqi H, Mathiasen JR, Dicamillo A, Huffman MJ, McKenna BA, Kopec K, Lu LD, Brown R, Qian J, Angeles T, Connors T, Spais C, Holskin B, Galinis D, Duzic E, Schaffhauser H, Rosse GC.
    Bioorg Med Chem Lett; 2012 Jan 01; 22(1):120-3. PubMed ID: 22153937
    [Abstract] [Full Text] [Related]

  • 10. Assessing the cardiac safety of ebastine. Epilogue.
    Roberts DJ.
    Drug Saf; 1999 Jan 01; 21 Suppl 1():89-92. PubMed ID: 10597871
    [No Abstract] [Full Text] [Related]

  • 11. New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
    Brea J, Rodrigo J, Carrieri A, Sanz F, Cadavid MI, Enguix MJ, Villazón M, Mengod G, Caro Y, Masaguer CF, Raviña E, Centeno NB, Carotti A, Loza MI.
    J Med Chem; 2002 Jan 03; 45(1):54-71. PubMed ID: 11754579
    [Abstract] [Full Text] [Related]

  • 12. Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.
    Filla SA, Mathes BM, Johnson KW, Phebus LA, Cohen ML, Nelson DL, Zgombick JM, Erickson JA, Schenck KW, Wainscott DB, Branchek TA, Schaus JM.
    J Med Chem; 2003 Jul 03; 46(14):3060-71. PubMed ID: 12825944
    [Abstract] [Full Text] [Related]

  • 13. Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist.
    Riemer C, Borroni E, Levet-Trafit B, Martin JR, Poli S, Porter RH, Bös M.
    J Med Chem; 2003 Mar 27; 46(7):1273-6. PubMed ID: 12646038
    [Abstract] [Full Text] [Related]

  • 14. Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel.
    Potet F, Bouyssou T, Escande D, Baró I.
    J Pharmacol Exp Ther; 2001 Dec 27; 299(3):1007-12. PubMed ID: 11714889
    [Abstract] [Full Text] [Related]

  • 15. [Synthesis and biological activities of new 5-HT2A selective ligands--N-substituted-piperidinyl-4-phenylthioether and sulfone derivatives].
    Wang H, Wen R, Huang L, Bi R, Tan PZ.
    Yao Xue Xue Bao; 2001 Apr 27; 36(4):274-7. PubMed ID: 12580055
    [Abstract] [Full Text] [Related]

  • 16. 1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists.
    Dowd CS, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA.
    J Med Chem; 2000 Aug 10; 43(16):3074-84. PubMed ID: 10956215
    [Abstract] [Full Text] [Related]

  • 17. Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current.
    Butrous G, Siegel RL.
    Circulation; 2001 Jun 12; 103(23):E119-20; author reply E119-20. PubMed ID: 11401951
    [No Abstract] [Full Text] [Related]

  • 18. 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists.
    Crawforth J, Goodacre S, Maxey R, Bourrain S, Patel S, Marwood R, O'Connor D, Herbert R, Hutson P, Rowley M.
    Bioorg Med Chem Lett; 2000 Dec 18; 10(24):2701-3. PubMed ID: 11133072
    [Abstract] [Full Text] [Related]

  • 19. Congenital and acquired long QT syndrome.
    Camm AJ, Janse MJ, Roden DM, Rosen MR, Cinca J, Cobbe SM.
    Eur Heart J; 2000 Aug 18; 21(15):1232-7. PubMed ID: 10924312
    [No Abstract] [Full Text] [Related]

  • 20. N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.
    Russell MG, Baker RJ, Barden L, Beer MS, Bristow L, Broughton HB, Knowles M, McAllister G, Patel S, Castro JL.
    J Med Chem; 2001 Nov 08; 44(23):3881-95. PubMed ID: 11689074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.